Passage Bio Inc (PASG) Event May 16, 2022, 00:00 UTC (52% Neutral) PASSAGE BIO, INC. (PASG) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:59 a.m. 🏢 Passage Bio Inc (PASG) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-16 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-38.88M $-42.81M $3.93M +9.18% 📉 Total Assets $355.08M $333.22M $21.85M +6.56% 📈 Total Liabilities $36.42M $51.91M $-15.49M -29.85% 📈 Stockholders' Equity $441.50M $-209.78M $651.28M +310.46% 📈 Operating Income/Loss $-38.93M $-42.81M $3.88M +9.06% 📉 Earningspersharebasic $-0.76 $-0.79 $0.03 +3.80% ➡️ Earningspersharediluted $-0.76 $-0.79 $0.03 +3.80% ➡️ 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Passage Bio Inc (PASG) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document